- Tofacitinib Impurity B
-
- $0.00 / 100mg
-
2025-12-16
- CAS:1092578-48-7
- Min. Order: 10mg
- Purity: 98
- Supply Ability: 100000
- Tofacitinib Impurity B
-
- $0.00 / 10mg
-
2025-09-25
- CAS:1092578-48-7
- Min. Order: 10mg
- Purity: 0.98
- Supply Ability: 10g
|
| | 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Basic information |
| Product Name: | 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile | | Synonyms: | YYMGYZDHOQYMFO-DGCLKSJQSA-N;(3S,4R)-4-Methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-1-piperidinepropanenitrile;3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile;(3S,4R)-4-Methyl-3-(Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-ylaMino)-beta-oxo-1-piperidinepropanenitrile;(3S,4R)-Tofacitinib;Tofacitinib Impurity B(3S,4R);Tofacitinib Impurity FD+DX;Tofacitinib Impurity B (3S,4R)-Tofacitinib | | CAS: | 1092578-48-7 | | MF: | C16H20N6O | | MW: | 312.3696 | | EINECS: | | | Product Categories: | GYL | | Mol File: | 1092578-48-7.mol | ![3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Structure](CAS/GIF/1092578-48-7.gif) |
| | 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Chemical Properties |
| density | 1.296 | | storage temp. | Store at -20°C | | solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | | form | Powder | | pka | 6.04±0.60(Predicted) | | InChI | InChI=1/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13-/s3 | | InChIKey | UJLAWZDWDVHWOW-PZILLZCRNA-N | | SMILES | C(#N)CC(N1CC[C@@H](C)[C@H](N(C)C2=NC=NC3NC=CC=32)C1)=O |&1:7,9,r| |
| | 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Usage And Synthesis |
| Uses | (3S,4R)-Tofacitinib is an enantiopure stereoisomer of the drug, Janus kinase 3(Jak3) inhibitor (CP-690,550) that has been found to inhibit selected members of the STE7 and STE20 subfamily of kinases. |
| | 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile Preparation Products And Raw materials |
|